Accelerated approvals will no longer be granted based on overall response rates in single-arm trials. A case series demonstrated the effectiveness of a novel trio for pediatric plasmacytic PTLD. A recently approved TIW schedule provides new option for patients with ALL or LBL receiving asparaginase. Interprofessional team-based care is the standard for patients undergoing HSCT. But who belongs on the team? Robert E. Brown, MD, and collaborating researchers from the University of Texas Health Science Center at Houston McGovern ... A study published in the Journal of Cancer Research and Clinical Oncology discussed outcomes of anti-CD20-based combination ... Data on diffuse large B-cell lymphoma (DLBCL) from the OncoCollect Lymphoma group registry were recently published in ... A study published in European Radiology examined the prognostic efficacy of automatic segmentation of diffuse large B-cell ... According to a study published in the International Journal of Radiation Oncology, Biology, Physics, approximately 50% of ... According to an article in Translational Cancer Research, data on the clinical outcomes of patients with primary diffuse ... Recent first-line randomized controlled trials (RCTs) for patients with diffuse large B-cell lymphoma (DLCBL) have ... The prevalence of diffuse large b-cell lymphoma (DLBCL) necessitates a thorough understanding of its gene expression profile; ... Researchers, led by Wenyujing Zhou, aimed to determine the benefits and risks of anti-CD19 chimeric antigen receptor (CAR) ... Italian researchers, led by Mario Petrini, postulated that subcutaneous (SC) rituximab could be advantageous compared to ... For patients over 65 years old with diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL) that have relapsed or ... Ferroptosis is an iron-dependent programmed cell death caused by lipid peroxidation; however, according to a study published ... Noting that diffuse large B-cell lymphoma (DLBCL) generally occurs in elderly individuals, researchers Cancan Luo, Han Lie, ... Citing an unmet clinical need in the identification and understanding of prognostic biomarkers for aggressive B-cell ... In a study, published in Diagnostics, researchers evaluated whether fludeoxyglucose (FDG) positron emission tomography (PET) ... Researchers, led by Jie Wang, MD, MS, conducted a network meta-analysis of randomized controlled trials to compare targeted ...